Addiction Toxicology Case Conference - September 2023

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center in Rochester New York.  He is Board Certified in Medical Toxicology and Addiction Medicine and practices in Addiction Toxicology with a mix of clinical,  research, teaching, and other professional work.  Dr. Wiegand has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and he is currently serving on the Board of Directors for the American Society of Addiction Medicine (ASAM) completing a term on the Executive Counsel as Vice President of ASAM.  He begins a two-year term as Treasurer of ASAM in April 2023.  Dr. Wiegand founded and led the Toxicology service at URMC until 2022 when he became Director of Addiction Medicine and Director of Addiction Medicine Consults also at URMC in the Department of Emergency Medicine.  Dr. Wiegand has served as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and he is the Fellowship Director for the URMC Medical Toxicology fellowship expecting to formally begin once accredited, in July of 2023.

Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.

Dr. Kenneth R. Conner is a clinical psychologist who serves as Professor in Emergency Medicine and Psychiatry at the University of Rochester Medical Center. He has conducted research on alcohol- and drug use and suicidal behavior for approximately 18 years, his work has been widely published, and he has received funding from multiple agencies including the National Institutes of Health, Department of Veterans Affairs, Department of Defense, Centers for Disease Control and Prevention, and the American Foundation for Suicide Prevention. He enjoys mentoring and has provided mentorship to numerous junior faculty members and postdoctoral fellows including three Career Development Awardees. Historically, much of Dr. Conner's work sought to examine etiological relationships between alcohol- and drug use and suicidal behavior. More recently, he initiated a program of intervention research including as multiple PI of a study of a brief intervention to promote behavioral health treatment-seeking in at-risk military service members and Veterans, and as PI of a treatment development study to examine a brief intervention for use with individuals with alcohol- or drug use problems who have been hospitalized following a suicide attempt. He is also developing projects to prevent unintentional drug overdose.